Chapter 21. Interstitial Lung Disease in the Elderly
- Stephen Jackson Professor of Geriatric Medicine2,
- Paul Jansen3,
- Arduino Mangoni4
Published Online: 2 APR 2009
DOI: 10.1002/9780470017975.ch21
Copyright © 2009 John Wiley & Sons, Ltd
Book Title

Prescribing for Elderly Patients
Additional Information
How to Cite
Bowden, J. (2009) Interstitial Lung Disease in the Elderly, in Prescribing for Elderly Patients (eds S. Jackson, P. Jansen and A. Mangoni), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470017975.ch21
Editor Information
- 2
Department of Clinical Gerontology, King's College Hospital, London, UK
- 3
Department of Geriatric Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands
- 4
Department of Clinical Pharmacology, Flinders University, Flinders Medical Centre, Adelaide, Australia
Publication History
- Published Online: 2 APR 2009
- Published Print: 27 MAY 2009
ISBN Information
Print ISBN: 9780470024287
Online ISBN: 9780470017975
- Summary
- Chapter
Keywords:
- treatment of interstitial lung disease (ILD);
- aetiology of interstitial lung disease;
- interstitial lung disease in elderly;
- assessing response to therapy;
- mechanism of action—azathioprine, a purine analog;
- methotrexate (MTX) - antimetabolite with immunosuppressive and anti-inflammatory properties;
- sarcoidosis - multisystem granulomatous disorder of unknown aetiology manifested by non-caseating infiltration;
- bronchiolitis obliterans organizing pneumonia (BOOP);
- hypersensitivity pneumonitis
Summary
This chapter contains sections titled:
Introduction
Presentation of interstitial lung disease
Particular problems in the elderly
General comments with regard to therapy
Assessing the response to therapy
Drugs used in ILD
Treatment for specific forms of lung disease
Key points
Links
References
